Digital concepts in post-stroke care pathways: adding value and minimizing burden
Neurological Research and Practice volume 3, Article number: 54 (2021)
In their manuscript “The PostStroke Manager—combining mobile, digital and sensor-based technology with personal assistance: protocol of the feasibility study” Michalski et al. describe an innovative and intersectoral care pathway for post-stroke patients integrating telemedical approaches.
Indeed, new technologies can help to improve patient management after acute medical emergencies or in chronic diseases. For example, randomized controlled trials have shown that the telemedical management can lead to significantly reduced mortality and re-hospitalisation rates in patients with chronic heart failure [1, 2].
The pathway for post-stroke management is still a matter of perceived weakness and intense research. Studies so far have focused on structured, repeated in person follow-ups with strict goals for key surrogate parameters of secondary prevention such as LDL-levels, blood pressure control and physical activity [3, 4]. Including digital technology into such a structured post-stroke pathway is promising. However, integrating such digital approaches should not only focus on clinical aspects but need to investigate care-relevant aspects as well. This should include analyzes not only on financial aspects but also consumption of other i.e. human resources of the health care system—both of which are precious and restricted. Consequentially, analyzes on these points are a prerequisite for funding on innovative care by the Federal Joint Committee (Gemeinsamer Bundesausschuss, GBA) in Germany. Primary data collected in the project are often evaluated together with secondary data from statutory health insurances.
To show feasibility of a digital approach in a trial is just a first step. What would be the use of a feasible innovative care concept if the effort required to implement it in clinical daily routine would be disproportionately high leading to a perceived burden rather than a relief? A major concern is that such structured care-pathways, especially those combining conventional in-person follow-up with additional digital methods, may provide overtreatment to patients without the need of further support while still not reaching those with needs. This problem may even be accentuated by the digital, telemedical approach because the usage of such media is often pronounced in more organized, digitally educated, younger and healthier subpopulations. Research should address intersectoral and multiprofessional care components in a needs-oriented manner. Taking this into account digital care has on the other side the potential to provide a stepped care approach with the right level of care for the individual patients instead of a “one size fits all” approach.
A key safety issue is the validity and reliability of data generated by digital devices in studies. It is mandatory that all digital components providing key data are derived from technology certified as medical device in accordance with the regulatory requirements of the European Medical Device Regulation (MDR). The same holds true for data protection of digital solutions. Failure in these aspects may not only lead to direct safety issues for the individual patient but may also jeopardize the acceptance of the digital approach in total.
In the end, besides proven feasibility as well as efficacy, innovative care concepts can only reach clinical reality if all involved stakeholders (patients, physicians, service providers etc.) experience an added value compared to previous approaches. In addition to the classical clinical endpoints, evidence-generating studies should therefore examine patient-related outcome (PROMs) or experience measurements (PREMs). Even if these endpoints are often seen as “soft factors” within the medical community, they are decisive factors in whether innovative care concepts will proof practicability in clinical daily routine. Only sufficient evidence including the above-mentioned aspects can be the basis for implementing innovative concepts into standard care with reimbursement by health insurances.
Hindricks, G., Taborsky, M., Glikson, M., Heinrich, U., Schumacher, B., Katz, A., et al. (2014). Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): A randomised controlled trial. Lancet (London, England), 384(9943), 583–590.
Koehler, F., Koehler, K., Deckwart, O., Prescher, S., Wegscheider, K., Kirwan, B. A., et al. (2018). Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): A randomised, controlled, parallel-group, unmasked trial. Lancet (London, England), 392(10152), 1047–1057.
Ahmadi, M., Laumeier, I., Ihl, T., Steinicke, M., Ferse, C., Endres, M., et al. (2020). A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): An open-label, randomised controlled trial. Lancet Neurology, 19(1), 49–60.
Eichner, F. A., Schwarzbach, C. J., Keller, M., Haeusler, K. G., Hamann, G. F., Sander, D., et al. (2020). Trial design and pilot phase results of a cluster-randomised intervention trial to improve stroke care after hospital discharge—The structured ambulatory post-stroke care program (SANO). European Stroke Journal, 6(2), 213–221.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Schöbel, C., Köhrmann, M. Digital concepts in post-stroke care pathways: adding value and minimizing burden. Neurol. Res. Pract. 3, 54 (2021). https://doi.org/10.1186/s42466-021-00150-z